USPH US Physical Therapy
WatchlistUS Physical Therapy News
JP Morgan Maintains Overweight on US Physical Therapy, Lowers Price Target to $99
JP Morgan analyst Calvin Sternick maintains US Physical Therapy (NYSE:USPH) with a Overweight and lowers the price target from $108 to $99.
US Physical Therapy(USPH.US) Officer Sells US$131.09K in Common Stocks
$US Physical Therapy(USPH.US)$ Officer REEVE GRAHAM D. sold 1,500 shares of Common Stocks on Nov 15, 2023 at an average price of $87.39 for a total value of $131.09K.Source: Announcement What is state
U S Physical Therapy Inc /nv Insider Sold Shares Worth $131,085, According to a Recent SEC Filing
Graham D. Reeve, COO, on November 15, 2023, sold 1,500 shares in U S Physical Therapy Inc /nv (USPH) for $131,085. Following the Form 4 filing with the SEC, Reeve has control over a total of 19,691 sh
U.S. Physical Therapy Insiders Sell US$4.8m Of Stock, Possibly Signalling Caution
The fact that multiple U.S. Physical Therapy, Inc. (NYSE:USPH) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When analyzing
US Physical Therapy(USPH.US) Director Buys US$82,340 in Common Stocks
$US Physical Therapy(USPH.US)$ Director Gilmartin Kathleen A purchased 1,000 shares of Common Stocks on Nov 10, 2023 at an average price of $82.34 for a total value of $82,340.Source: Announcement Wha
We Wouldn't Be Too Quick To Buy U.S. Physical Therapy, Inc. (NYSE:USPH) Before It Goes Ex-Dividend
Barrington Cuts Price Target on U.S. Physical Therapy to $111 From $124 on 'Tough Stock Market Environment', Reiterates Outperform Rating
Barrington Cuts Price Target on U.S. Physical Therapy to $111 From $124 on 'Tough Stock Market Environment', Reiterates Outperform Rating.
Analysts Offer Insights on Healthcare Companies: US Physical Therapy (USPH) and CareDx (CDNA)
U.S. Physical Therapy Declares $0.43 Dividend
Potential Growth and Buy Rating for US Physical Therapy Despite Lower Q4 Outlook and Adjusted Price Objective
US Physical Therapy To Go Ex-Dividend On November 15th, 2023 With 0.43 USD Dividend Per Share
November 8th - $US Physical Therapy(USPH.US)$ is trading ex-dividend on November 15th, 2023. Shareholders of record on November 16th, 2023 will receive 0.43 USD dividend per share on December 8th,
U.S. Physical Therapy Expects The Company's Adjusted EBITDA For 2023 To Be Within Its Previously Provided Guidance Range Of $75M-$80M
2023 EARNINGS GUIDANCEManagement currently expects the Company's Adjusted EBITDA for 2023 to be within its previously provided guidance range of $75.0 million to $80.0 million, most likely in the low-
Earnings Flash (USPH) U.S. PHYSICAL THERAPY Posts Q3 Revenue $150M, Vs. Street Est of $148.9M
04:31 PM EST, 11/07/2023 (MT Newswires) -- Earnings Flash (USPH) U.S. PHYSICAL THERAPY Posts Q3 Revenue $150M, vs. Street Est of $148.9M
US Physical Therapy Q3 EPS $0.62 Beats $0.61 Estimate, Sales $150.01M Beat $148.92M Estimate
US Physical Therapy (NYSE:USPH) reported quarterly earnings of $0.62 per share which beat the analyst consensus estimate of $0.61 by 1.64 percent. This is a 6.9 percent increase over earnings of $0.58
U.S. Physical Therapy (NYSE:USPH) Stock Falls 4.3% in Past Week as Five-year Earnings and Shareholder Returns Continue Downward Trend
For many, the main point of investing is to generate higher returns than the overall market. But the main game is to find enough winners to more than offset the losers At this point some shareholder
U.S. Physical Therapy, Inc. Schedules Third Quarter 2023 Earnings Release and Conference Call Date
U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the
Is It Too Late To Consider Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?
While U.S. Physical Therapy, Inc. (NYSE:USPH) might not be the most widely known stock at the moment, it saw significant share price movement during recent months on the NYSE, rising to highs of
U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly, we'll want to see a proven return on capital employed (ROCE) that is increasing, a
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
UpgradesFor Agile Therapeutics Inc (NASDAQ:AGRX), Maxim Group upgraded the previous rating of Hold to Buy. For the second quarter, Agile Therapeutics had an EPS of $3.10, compared to year-ago quarter
JP Morgan Initiates Coverage On US Physical Therapy With Overweight Rating, Announces Price Target of $108
JP Morgan analyst Calvin Sternick initiates coverage on US Physical Therapy (NYSE:USPH) with a Overweight rating and announces Price Target of $108.